Exploring the Complex Ethical Challenges Associated with Living Donor Kidney Transplantation
DOI:
https://doi.org/10.71749/pkj.77Keywords:
Informed Consent, Kidney Transplantation/ethics, Living Donors, Personal AutonomyAbstract
Living donor kidney transplantation is regarded as the best treatment for selected patients with end ‑stage renal disease, associated with improved survival and quality of life. However, it should be recognized as a distinct medical procedure during which an organ is procured from a healthy individual for the benefit of another patient. Seven decades after the first successful procedure, ethical constraints persist, even though the procedure has become routine worldwide. The perceived risks for donors are considered low and ethically acceptable; however, recent studies have identified increased long‑term risks of end ‑stage renal disease for living donors compared to healthy non ‑donors, raised hypertensive disorders during pregnancy, and a possible increase in mortality. Additionally, in most centers, there is a growing acceptance of donors with minor abnormalities, which were previously declined, yet long ‑term follow ‑up data on these donors remains scarce. Furthermore, various risks and benefits must be evaluated, including the potential risks from refusing donations and possible lifesaving opportunities arising from conditions identified during the evaluation process. A thorough assessment of the candidate donor’s risks is essential. While current literature helps us mitigate significant risks for the candidate donor, it is important to elaborate on these risks with greater precision. Maintaining ethical practices and ensuring informed consent requires an updated registry of all living donors and candidates, along with long ‑term follow ‑up that includes ongoing data reviews.Downloads
References
Organization Nobel Prize. The Nobel Prize in Physiology or Medicine 1990. [Accessed Dec 2024] Available from: https://www.nobelprize.org/prizes/medicine/1990/murray/25012-joseph-e-murray-nobel-lecture-1990/.
Global Observatory on Donation and Transplantation [Accessed Dec 2024] Available from: https://www.transplant-observatory.org.
Massie AB, Motter JD, Snyder JJ, Levan ML, Segev DL. Thirty-Year Trends in Perioperative Mortality Risk for Living Kidney Donors. JAMA. 2024;332:1015–7. doi:10.1001/jama.2024.14527.
Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, et al. Long-term risks for kidney donors. Kidney Int. 2014;86:162–7. doi:10.1038/ki.2013.460.
Muzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB, et al. Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors. Am J Transplant. 2017;17:1823–32. doi:10.1111/ajt.14235.
Reese PP, Boudville N, Garg AX. Living kidney donation: outcomes, ethics, and uncertainty. Lancet. 2015;385:2003–13. doi:10.1016/S0140-6736(14)62484-3.
National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. United States Renal Data System, 2023 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Bethesda: NIH, NIDDKD; 2023.
European Committee on Organ Transplantation. Newsletter Transplant - International figures on donation and transplantation 2023. Strasbourg: ECOT; 2024.
Sociedade Portuguesa de Nefrologia. Registo Nacional da Doença Renal Crónica - Gabinete de Registo da Doença Renal Crónica da Sociedade Portuguesa de Nefrologia. [Accessed Jan 2025] Available from: https://www.spnefro.pt/assets/relatorios/tratamento_doenca_terminal/er-2024---registo-atualizado.pdf.
Beauchamp TL. Principles of biomedical ethics. 6th ed. Oxford: Oxford University Press; 2009.
Frutos MÁ, Crespo M, de la Oliva Valentín M, Hernández D, de Sequera P, Domínguez-Gil B, et al. Living-donor kidney transplant: guidelines with updated evidence. Nefrologia. 2022;42 Suppl 2:1–4. doi:10.1016/j.nefroe.2022.01.009. Erratum in: Nefrologia. 2023:S2013-2514(23)00024-X. doi:10.1016/j.nefroe.2023.02.001.
Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V, et al. KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation. 2020;104:S11–S103. doi:10.1097/TP.0000000000003136.
Andrews PA, Burnapp L. British Transplantation Society / Renal Association UK Guidelines for Living Donor Kidney Transplantation 2018: Summary of Updated Guidance. Transplantation. 2018;102:e307. doi:10.1097/TP.0000000000002253.
Kortram K, Lafranca JA, IJzermans JN, Dor FJ. The need for a standardized informed consent procedure in live donor nephrectomy: a systematic review. Transplantation. 2014;98:1134–43. doi:10.1097/TP.0000000000000518.
Grossi AA, Sever MS, Hellemans R, Mariat C, Crespo M, Watschinger B, et al. The 3-Step Model of informed consent for living kidney donation: a proposal on behalf of the DESCaRTES Working Group of the European Renal Association. Nephrol Dial Transplant. 2023;38:1613–22. doi:10.1093/ndt/gfad022.
Reese PP, Caplan AL, Kesselheim AS, Bloom RD. Creating a medical, ethical, and legal framework for complex living kidney donors. Clin J Am Soc Nephrol. 2006;1:1148–53. doi:10.2215/CJN.02180606.
Ahmadi AR, Lafranca JA, Claessens LA, Imamdi RM, IJzermans JN, Betjes MG, et al. Shifting paradigms in eligibility criteria for live kidney donation: a systematic review. Kidney Int. 2015;87:31–45. doi:10.1038/ki.2014.118.
Lentine KL, Segev DL. Understanding and Communicating Medical Risks for Living Kidney Donors: A Matter of Perspective. J Am Soc Nephrol. 2017;28:12–24. doi:10.1681/ASN.2016050571.
Mamode N, Van Assche K, Burnapp L, Courtney A, van Dellen D, Houthoff M, et al. Donor Autonomy and Self-Sacrifice in Living Organ Donation: An Ethical Legal and Psychological Aspects of Transplantation (ELPAT) View. Transpl Int. 2022;35:10131. doi:10.3389/ti.2022.10131.
Gruessner RW, Gruessner AC. Solid-organ Transplants From Living Donors: Cumulative United States Experience on 140,156 Living Donor Transplants Over 28 Years. Transplant Proc. 2018;50:3025–35. doi:10.1016/j.transproceed.2018.07.024.
Park YH, Min SK, Lee JN, Lee HH, Jung WK, Lee JS, et al. Comparison of survival probabilities for living-unrelated versus cadaveric renal transplant recipients. Transplant Proc. 2004;36:2020–2. doi:10.1016/j.transproceed.2004.08.122.
Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010;303:959–66. doi:10.1001/jama.2010.237.
Johnson EM, Anderson JK, Jacobs C, Suh G, Humar A, Suhr BD, et al. Long-term follow-up of living kidney donors: quality of life after donation. Transplantation. 1999;67:717–21. doi:10.1097/00007890-199903150-00013.
Fehrman-Ekholm I, Brink B, Ericsson C, Elinder CG, Dunér F, Lundgren G. Kidney donors don’t regret: follow-up of 370 donors in Stockholm since 1964. Transplantation. 2000;69:2067–71. doi:10.1097/00007890-200005270-00016.
Tong A, Chapman JR, Wong G, Kanellis J, McCarthy G, Craig JC. The motivations and experiences of living kidney donors: a thematic synthesis. Am J Kidney Dis. 2012;60:15–26. doi:10.1053/j.ajkd.2011.11.043.
Rodrigue JR, Paek M, Whiting J, Vella J, Garrison K, Pavlakis M, et al. Trajectories of perceived benefits in living kidney donors: association with donor characteristics and recipient outcomes. Transplantation. 2014;97:762–8. doi:10.1097/01.TP.0000437560.23588.ef.
Lopes A, Frade IC, Teixeira L, Oliveira C, Almeida M, Dias L, et al. Depression and anxiety in living kidney donation: evaluation of donors and recipients. Transplant Proc. 2011;43:131–6. doi:10.1016/j.transproceed.2010.12.028.
Allen MB, Abt PL, Reese PP. What are the harms of refusing to allow living kidney donation? An expanded view of risks and benefits. Am J Transplant. 2014;14:531–7. doi:10.1111/ajt.12599.
Reese PP, Allen MB, Carney C, Leidy D, Levsky S, Pendse R, et al. Outcomes for individuals turned down for living kidney donation. Clin Transplant. 2018;32:e13408. doi:10.1111/ctr.13408.
Van Pilsum Rasmussen SE, Henderson ML, Kahn J, Segev DL. Considering Tangible Benefit for Interdependent Donors: Extending a Risk–Benefit Framework in Donor Selection. Am J Transplant. 2017;17:2567–71. doi:10.1111/ajt.14319.
Veríssimo R, Almeida M, Oliveira JP, Pereira PR, Ribeiro BO, Pedroso S, et al. Why Donors Do Not Donate: A Living Donation Program Experience. Transplant Proc. 2022;54:1197–201. doi:10.1016/j.transproceed.2022.02.066.
Van Pilsum Rasmussen SE, Robin M, Saha A, Eno A, Lifshitz R, Waldram MM, et al. The Tangible Benefits of Living Donation: Results of a Qualitative Study of Living Kidney Donors. Transplant Direct. 2020;6:e626. doi:10.1097/TXD.0000000000001068.
Park SC, Shapiro R, Good D, Lopez R, Shah N, Sood P, et al. The living donor evaluation as a life-saving event. Clin Transplant. 2023;37:e14885. doi:10.1111/ctr.14885.
Lafranca JA, Spoon EQ, van de Wetering J, IJzermans JN, Dor FJ. Attitudes among transplant professionals regarding shifting paradigms in eligibility criteria for live kidney donation. PLoS One. 2017;12:e0181846. doi:10.1371/journal.pone.0181846.
Katz-Greenberg G, Shah S. Sex and Gender Differences in Kidney Transplantation. Semin Nephrol. 2022;42:219–29. doi:10.1016/j.semnephrol.2022.04.011.
Global Observatory on Donation and Transplantation. International Report on Organ Donation and Transplantation 2021. [accessed Dec 2024] Available from: https://www.transplant-observatory.org/wp-content/uploads/2023/11/2022-data-global-report_VF_2.pdf
Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14:151–64. doi:10.1038/nrneph.2017.181.
Brar A, Markell M. Impact of gender and gender disparities in patients with kidney disease. Curr Opin Nephrol Hypertens. 2019;28:178–82. doi:10.1097/MNH.0000000000000482.
Kurnikowski A, Krenn S, Lewandowski MJ, Schwaiger E, Tong A, Jager KJ, et al. Country-specific sex disparities in living kidney donation. Nephrol Dial Transplant. 2022;37:595–8. doi:10.1093/ndt/gfab305.
Portugal. Lei n.º 2/2015 – Diário da República n.º 5/2015, Série I de 2015-01-08.
European Union. Directive 2010/45/EU of the European Parliament and of the Council of 7 July 2010 on standards of quality and safety of human organs intended for transplantation. [accessed Jan 2025] Available at: https://eur-lex.europa.eu/eli/dir/2010/53/oj/eng
Ministério da Saúde, Gabinete do Secretário de Estado Adjunto do Ministro da Saúde. Diário da República, 2.ª série — N.º 40 — 26 de fevereiro de 2015 Despacho n.º 2055/2015, 26 de fevereiro.
Lentine KL, Schnitzler MA, Xiao H, Saab G, Salvalaggio PR, Axelrod D, et al. Racial variation in medical outcomes among living kidney donors. N Engl J Med. 2010;363:724–32. doi:10.1056/NEJMoa1000950.
Cazauvieilh V, Moal V, Prudhomme T, Pecoraro A, Piana A, Campi R, et al. Psychological Impact of Living Kidney Donation: A Systematic Review by the EAU-YAU Kidney Transplant Working Group. Transpl Int. 2023;36:11827. doi:10.3389/ti.2023.11827.
Kasiske BL, Ahn YS, Conboy M, Dew MA, Folken C, Levan M, et al. Outcomes of Living Kidney Donor Candidate Evaluations in the Living Donor Collective Pilot Registry. Transplant Direct. 2021;7:e689. doi:10.1097/TXD.0000000000001143.
Lentine KL, Lam NN, Segev DL. Risks of Living Kidney Donation: Current State of Knowledge on Outcomes Important to Donors. Clin J Am Soc Nephrol. 2019;14:597–608. doi:10.2215/CJN.11220918.
Thiel GT, Nolte C, Tsinalis D. Prospective Swiss cohort study of living-kidney donors: study protocol. BMJ Open. 2011;1:e000202. doi:10.1136/bmjopen-2011-000202.
Haugen AJ, Hallan S, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, et al. Increased risk of ischaemic heart disease after kidney donation. Nephrol Dial Transplant. 2022;37:928–36. doi:10.1093/ndt/gfab054.
Clayton PA, Saunders JR, McDonald SP, Allen RD, Pilmore H, Saunder A, Boudville N, Chadban SJ. Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004–2012. Transplantation. 2016;100:1278–83. doi:10.1097/TP.0000000000000877.
Manyalich M, Ricart A, Martínez I, Balleste C, Paredes D, Vilardell J, et al. EULID project: European living donation and public health. Transplant Proc. 2009 Jul-Aug;41(6):2021–4. doi:10.1016/j.transproceed.2009.05.021.
Lentine KL, Schnitzler MA, Garg AX, Xiao H, Axelrod D, Tuttle-Newhall JE, et al. Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation. 2015;99:1723–9. doi:10.1097/TP.0000000000000733.
Instituto Português do Sangue e da Transplantação [Accessed Dec 2024] Available from: https://www.ipst.pt/files/PressReleaseIPST_AtividadeDoacaoTransplantacao2023__21Maio2024.pdf.
Sociedade Portuguesa de Transplantação. Annual Registry 2020. [Accessed Dec 2024] Available from: https://spt.pt/wp-content/uploads/2022/03/RSPT2020-RIM.pdf.
World Health Organization. Increasing availability, ethical access and oversight of transplantation of human cells, tissues and organs. Geneva: WHO; 2024.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Manuela Almeida, Domingos Machado (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
